HIKMA PHARMACEUTICALS - stock earnings
HKMPF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 134.8 million USD | 1.5 billion USD |
| 2022Q4 | 15.4 million USD | 1.3 billion USD |
| 2022Q3 | 7.5 million USD | 652.0 million USD |
| 2022Q2 | 162.4 million USD | 1.1 billion USD |
| 2022Q1 | 86.5 million USD | 606.5 million USD |
| 2021Q4 | 171.6 million USD | 1.3 billion USD |
| 2021Q2 | 246.7 million USD | 1.2 billion USD |
| 2020Q4 | 229.3 million USD | 1.3 billion USD |
| 2020Q2 | 208.0 million USD | 1.1 billion USD |
| 2019Q4 | 316.8 million USD | 1.2 billion USD |
| 2019Q3 | 150.5 million USD | 580.0 million USD |
| 2019Q2 | 182.0 million USD | 1.0 billion USD |
| 2019Q1 | 92.5 million USD | 523.5 million USD |
| 2018Q4 | 176.0 million USD | 1.1 billion USD |
| 2018Q3 | 88.0 million USD | 540.5 million USD |
| 2018Q2 | 106.0 million USD | 979.0 million USD |
| 2018Q1 | 53.0 million USD | 494.5 million USD |
| 2017Q4 | -912.0 million USD | 1.0 billion USD |
| 2017Q3 | -456.0 million USD | 520.5 million USD |
| 2017Q2 | 69.0 million USD | 895.0 million USD |
| 2017Q1 | 34.5 million USD | 447.5 million USD |
| 2016Q4 | 97.0 million USD | 1.1 billion USD |
| 2016Q3 | 48.5 million USD | 534.0 million USD |
| 2016Q2 | 58.0 million USD | 882.0 million USD |
| 2015Q4 | 118.0 million USD | 731.0 million USD |
| 2015Q2 | 134.0 million USD | 709.0 million USD |
| 2014Q4 | 109.0 million USD | 751.0 million USD |
| 2014Q2 | 169.0 million USD | 738.0 million USD |
| 2013Q4 | 139.0 million USD | 727.0 million USD |
| 2013Q2 | 73.0 million USD | 638.0 million USD |
HKMPF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 190.0 million USD | 2.9 billion USD |
| 2022 | 188.0 million USD | 2.5 billion USD |
| 2021 | 421.0 million USD | 2.6 billion USD |
| 2020 | 431.0 million USD | 2.3 billion USD |
| 2019 | 486.0 million USD | 2.2 billion USD |
| 2018 | 282.0 million USD | 2.1 billion USD |
| 2017 | -843.0 million USD | 1.9 billion USD |
| 2016 | 155.0 million USD | 2.0 billion USD |
| 2015 | 252.0 million USD | 1.4 billion USD |
| 2014 | 278.0 million USD | 1.5 billion USD |
| 2013 | 212.0 million USD | 1.4 billion USD |
| 2012 | 100.3 million USD | 1.1 billion USD |
| 2011 | 80.1 million USD | 918.0 million USD |
| 2010 | 98.8 million USD | 730.9 million USD |
| 2009 | 77.7 million USD | 636.9 million USD |
| 2008 | 57.1 million USD | 580.7 million USD |
| 2007 | 62.6 million USD | 448.8 million USD |
| 2006 | 54.5 million USD | 317.0 million USD |
| 2005 | 43.9 million USD | 262.2 million USD |
| 2004 | 37.5 million USD | 212.4 million USD |
| 2003 | 17.6 million USD | 105.1 million USD |
| 2002 | 10.5 million USD | 85.5 million USD |
HKMPF
Price: $24.50
Dividend Yield: 0.03%
Forward Dividend Yield: 3.84%
Payout Ratio: 110.59%
Dividend Per Share: 0.94 USD
Earnings Per Share: 0.85 USD
P/E Ratio: 35.85
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 5.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 13
DGR3: -5.62%
DGR5: 17.43%
DGR10: 16.71%